Trimetazidine

This page shows anti-doping rule violation data we have registered for Trimetazidine.

Number of cases in Trimetazidine Last 10 Years

Trimetazidine

Trimetazidine ranks #64 globally among prohibited substances, with 49 registered cases (0.3% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,828 verified cases. Russia leads with 14 cases, while Track and field is the most affected sport (17 cases).

Cases of Trimetazidine by Sport
Track and field
17
Wrestling
5
Weightlifting
4
Swimming
4
Rowing
3
Top Sport: Track and field

17

Track and field cases

0%

Of all violations

49

Total Trimetazidine cases
Track and field's share of Trimetazidine violations 0%
17 of 49

Track and field has the most recorded cases of Trimetazidine violations globally, with 17 registered cases — 0% of all 49 verified cases.

Cases of Trimetazidine by Country
Russia
14
Kenya
9
Ukraine
6
China
3
France
2
Top Country: Russia

14

Russia cases

28.6%

Of all violations

49

Total Trimetazidine cases
Russia's share of Trimetazidine violations 28.6%
14 of 49

Russia leads significantly in Trimetazidine violations globally, with 14 registered cases — 28.6% of all 49 verified cases.

Global Substance Ranking

Trimetazidine ranks #64 of 360 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,379
#2 Methandienone
843
#3 Norandrosterone
787
#4 Testosterone
772
···
#64 Trimetazidine
49
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 77.6%
38 cases
Female 22.4%
11 cases
Analysis: 's gender distribution (77.6% male, 22.4% female) aligns closely with the global average. Global average: 80.1% male, 19.9% female
Average Suspension Length
34.9
months
Trimetazidine
30.2
months
Global average

The average suspension for Trimetazidine violations is 34.9 months, longer than the global average of 30.2 months.

Trimetazidine is defined as a specified substance in the WADA Prohibited substances list in 2014. It was added because of emerging patterns of drug use. In it\'s first year on the list it was only prohibited in-competition. Since 2015 it is also prohibited out-of-competition. Trimetazidine is a medicine used to prevent angina attacks, which are sudden pains to the chest, jaw and back brought on by physical effort, due to reduced blood flow to the heart. Angina is commonly associated with a narrowing of the blood vessels that supply the heart, called the coronary arteries. Trimetazidine is a ‘metabolic agent’, a medicine which has an effect on metabolism (the process by which substances are broken down in the body). It is believed to protect against myocardial ischaemia (reduced blood supply to the heart muscle) by increasing the rate at which glucose is broken down. Trimetazidine is also used to treat the symptoms of vertigo (a spinning sensation) and tinnitus (ringing sensation in the ears), and to treat reduced vision and visual field disturbances (unclear or disturbed vision) due to problems affecting the blood vessels. Medicines containing trimetazidine have been available since the 1970s and are currently marketed in Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovakia, Slovenia and Spain. They are marketed under the invented name Vastarel and other trade names. Read more: Trimetazidine Hydrochloride (Adexor) Drug Information - Indications, Dosage, Side Effects and Precautions Medindia http://www.medindia.net/doctors/drug_information/trimetazidine_hydrochloride.htm#ixzz2u5QDjbws http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Trimetazidine/human_referral_000315.jsp&mid=WC0b01ac05805c516f

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,828 verified anti-doping rule violations across all sports and all countries, and is updated regularly.